Skip to main content
. 2022 Feb 6;11(6):1454–1464. doi: 10.1002/cam4.4569

FIGURE 6.

FIGURE 6

HeLa cells with repressed NCL levels were treated with the PI3K inhibitor LY294002 or the PI3K activator 740Y‐P. (A) Cell proliferation was determined using an MTT assay. (B) The expression levels of the apoptosis‐related genes were measured using RT‐PCR. *p < 0.05, **p < 0.01, versus the sh‐NT‐Hela group. # p < 0.05, ## p < 0.01, versus the sh‐NCL‐Hela group, n = 3. MTT, 3‐(4, 5‐dimethylthiazol‐2‐yl)‐2, 5‐diphenyltetrazolium bromide; NCL, nucleolin